PMID: 6409407Jun 1, 1983Paper

Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate

Cancer Treatment Reviews
L DewitE Van der Schueren

Abstract

In the last two decades, many authors have treated prostatic carcinoma by radiation therapy. Accumulated data have been updated, after 10 and 15 years of follow-up. In stage A and B, the reported survival and local control rates after irradiation (20, 22, 30, 34, 35, 39, 42) are as good as in selected patients treated by radical prostatectomy (9, 18, 23). In stage C, the results after irradiation (20, 22, 30, 42) are better than after radical surgery (23, 43). However, patients are nonrandomly selected and the methods of statistical analysis differ. Therefore, a valid comparison cannot be made. The therapeutic ratio is determined by survival and local control, and also by therapy related complications. It is therefore of interest to find out from radiotherapy series if their incidence is related to the treatment technique. Unfortunately, relatively few studies accurately describe treatment technique and complications. Gastro-intestinal radiation injury becomes significant when the dose at the posterior rectal wall is 65-76 Gy and the length of the treated rectum is at least 10 cm. A hot spot of 80-84 Gy needs to be only 2 to 3 cm to increase the risk of late bowel stenosis. Genito-urinary complications are influenced by local e...Continue Reading

References

Mar 1, 1979·Cancer·W J TaylorM D Hafermann
Nov 1, 1978·International Journal of Radiation Oncology, Biology, Physics·N GreenL Kussin
Sep 1, 1977·International Journal of Radiation Oncology, Biology, Physics·W J NegliaD E Johnson
Jun 1, 1978·Cancer·L HarisiadisM Tannenbaum
Nov 1, 1976·International Journal of Radiation Oncology, Biology, Physics·B van der Werf-MessingD I Blonk
Apr 19, 1976·JAMA : the Journal of the American Medical Association·J A del Regato
Nov 1, 1976·The British Journal of Radiology·G F DeMûelenaere, A G Sandison
May 1, 1973·The Journal of Urology·M D CosgroveR Terry
Dec 1, 1972·The Journal of Urology·N B Phillips, J K Lattimer
Jan 4, 1971·JAMA : the Journal of the American Medical Association·V A Gilbertsen
Feb 5, 1968·JAMA : the Journal of the American Medical Association·H J JewettW M Shelley
May 1, 1969·The Journal of Urology·R H Flocks
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·M V PilepichC A Perez
Oct 1, 1982·International Journal of Radiation Oncology, Biology, Physics·K K Ang, E van der Schueren
Jan 1, 1981·International Journal of Radiation Oncology, Biology, Physics·J L Pino y TorresS E Order
Oct 1, 1981·International Journal of Radiation Oncology, Biology, Physics·M V PilepichF R Zivnuska
Jan 1, 1959·The Journal of Urology·R H FLOCKSR PORTO
Jul 1, 1962·The Journal of Urology·L J ARDUINO, M A GLUCKSMAN
Dec 1, 1964·British Journal of Urology·S N BUDHRAJA, J C ANDERSON

❮ Previous
Next ❯

Citations

Apr 1, 1986·World Journal of Surgery·J D CoxL E Olson
May 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J J FeldmeierR Alecu
Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·L B MarksM S Anscher
Sep 1, 1986·Clinical Radiology·C I PrestonG R Kerr
Jan 1, 1994·Seminars in Roentgenology·R A DuBrow
Jun 19, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P C O'Brien
Aug 6, 2002·European Urology·A ZurloUNKNOWN EORTC Radiotherapy and Genito-Urinary Tract Cancer Groups
Jul 1, 1997·International Journal of Radiation Oncology, Biology, Physics·V LingareddyM Mohiuddin
Mar 13, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D P Dearnaley
May 1, 1996·Australasian Radiology·C I Franklin
May 1, 1992·British Journal of Urology·R J ShearerD P Dearnaley
Jan 1, 1994·International Journal of Radiation Oncology, Biology, Physics·S A LeibelW F Whitmore
Jul 1, 1991·Geriatric Nursing·L L Lilley
Jul 1, 1995·Cancer Treatment Reviews·C L Schwartz
Nov 1, 1990·Journal of Pharmaceutical Sciences·P K Gupta
Jan 1, 1995·Seminars in Surgical Oncology·D P Dearnaley
Nov 4, 2000·The Journal of Urology·A Vaidya, M S Soloway
May 18, 2000·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·C D Ames, M Gray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.